Sebastien Beauzile lived with the chronic pain of sickle cell anemia. Now, thanks to a groundbreaking genetic treatment, he ...
Sickle cell anemia, first described in 1910, primarily affects people of African, Mediterranean and Middle Eastern descent.
Aaron Scott, of Fayetteville, is the first in North Carolina to receive a new FDA-approved therapy which uses the patient's own cells to relieve the pain of sickle cell disease.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results